Industry Bulletins | March 29, 2021
Brainscope Launches FDA-Cleared Point-Of-Care Concussion Assessment Device
BrainScope announced the availability of its third groundbreaking FDA-cleared algorithm for concussion assessment on the BrainScope device. The Concussion Index is the first physiological marker of concussive injury that helps clinical professionals objectively assess consumers at baseline, point of injury, and through recovery. The Concussion Index adds to the suite of FDA-cleared algorithms already available on the BrainScope device and in clinical use to rapidly triage suspected mild traumatic brain injuries (mTBI), from brain bleeds or concussion. BrainScope has been demonstrated to have the potential to reduce the use of head computerized axial tomography (CAT) Scans by more . . .